Atlas Trials

Study of Copanlisib in Hepatic or Renal Impairment

Clinical trial NCT03172884 · COMPLETED

Trial details

NCT number
NCT03172884
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Insufficiency, Renal Insufficiency
Start date
2017-06-14
Primary completion
2020-03-13
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.